Overexpression of the natural tetrapeptide acetyl‐N‐ser‐asp‐lys‐pro derived from thymosin β4 in neoplastic diseases
- 3 May 2010
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1194 (1) , 53-59
Abstract
The natural tetrapeptide acetyl‐ser‐asp‐lys‐pro (AcSDKP) is formed in vivo by enzymatic cleavage of the N terminus of thymosin β4 by prolyl oligopeptidase (POP). Recently, AcSDKP was shown to promote angiogenesis. Because of the critical role of neovascularization in cancer development, the levels of AcSDKP and POP activity in a number of different malignant tissues were investigated. Our studies revealed that AcSDKP levels were markedly elevated in neoplastic diseases including hematologic malignancies and solid neoplasms. Consistent with this finding, the enhanced activity of POP was also detected in all analyzed specimens of cancer tissues. Both these novel findings are in concert with the previously reported overexpression of thymosin β4 in a large variety of malignant tumors and with its potential role in cancerogenesis. The physiological relevance of these findings awaits further studies; however, our first results strongly suggest a key role for AcSDKP in the pathogenesis of cancer.Keywords
This publication has 33 references indexed in Scilit:
- The tetrapeptide acetyl‐serine‐aspartyl‐lysine‐proline improves skin flap survival and accelerates wound healingWound Repair and Regeneration, 2006
- Tetrapeptide AcSDKP Induces Postischemic Neovascularization Through Monocyte Chemoattractant Protein-1 SignalingArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Peptide Ac-SDKPHypertension, 2004
- The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivoBlood, 2003
- Angiogenesis in cancer and other diseasesNature, 2000
- Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells.Proceedings of the National Academy of Sciences, 1992
- Involvement of thymosin β4 and endoproteinase Asp‐N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic systemFEBS Letters, 1990
- Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure.Proceedings of the National Academy of Sciences, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971